Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Name: Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
License: Public Domain

Gilead Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti-hiv-agents combination drug-therapy hiv-infections

hiv infections, drug therapy, combination, reverse transcriptase inhibitors, anti-hiv agents, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Related documents